Business / Finance

RSS

Meridian Bioscience first quarter net sales decrease 12% to $37.3 million

Net sales for the first quarter of fiscal 2011 were $37,263,000 as compared to $42,457,000 for the same period of the prior fiscal year, a decrease of 12%. Net earnings for the first quarter of fiscal 2011 were $6,025,000, or $0.15 per diluted share, both decreases of 32% from the first quarter of fiscal 2010. Diluted common shares outstanding for the first quarter of fiscal 2011 and 2010 were 41,294,000 and 41,185,000, respectively.

20 Jan 2011

FDA approves Spectranetics PMA for manufacturing site change for CVX-300 laser system

Spectranetics Corporation today announced that the Food and Drug Administration (FDA) has approved the Company's premarket approval application (PMA) supplement requesting a manufacturing site change for the CVX-300® laser system.

20 Jan 2011

UnitedHealth Group reports net earnings of $4.10 per share for 2010

UnitedHealth Group today reported fourth quarter and full year 2010 financial results, including strong revenue growth from both its Health Benefits and Health Services business platforms. Full year and fourth quarter 2010 net earnings were $4.10 per share and $0.94 per share, respectively.

20 Jan 2011

Ingenix announces formation of new Life Sciences division

Ingenix, a leading provider of health care information, technology and consulting services, today announced the formation of Ingenix Life Sciences, a newly-organized division that focuses Ingenix's capabilities in assisting life sciences clients to identify, analyze and measure the value of their products.

20 Jan 2011

inVentiv Health signs definitive agreement to purchase i3 clinical development businesses from Ingenix

inVentiv Health, a leading provider of outsourced clinical development, launch and commercial services to the global health care industry, today announced it has signed a definitive agreement to purchase the i3 clinical development businesses from Ingenix.

20 Jan 2011

Cognizant to deliver commercial operations solutions to Lilly

Cognizant, a leading provider of consulting, technology, and business process outsourcing (BPO) services, announced that it has been selected by Eli Lilly and Company, one the world's leading innovation-driven pharmaceutical companies, to deliver an end-to-end set of services to help Lilly's U.S. sales and marketing operations be more effective, efficient, and innovative.

20 Jan 2011

Medidata extends Grants Manager web-based budgeting application with new Contracting module

Medidata Solutions, a leading global provider of SaaS-based clinical development solutions, today extended the Grants Manager® web-based budgeting application with a new Contracting module, enabling sites and sponsors to negotiate clinical trial site budgets directly online, eliminating the burden of managing hundreds of email messages and reducing budgeting cycle times.

20 Jan 2011

Waters signs land-purchase agreement with Royal Bank of Scotland for new MS Headquarters in UK

Waters Corporation today announced it signed a land-purchase agreement with The Royal Bank of Scotland for a new Mass Spectrometry Headquarters in Wilmslow, Cheshire, near Manchester, U.K.

20 Jan 2011

Precedent Health announces formal launch

Precedent Health, Inc., a healthcare company focused on aligning physicians, hospitals and payers by building innovative provider networks, today announced the formal launch of the company. Funding was provided by Heritage Group, LLC, TEXO Ventures, LLC and members of the founding executive team. The company will have its headquarters in Nashville, TN along with a satellite office in Austin, TX.

20 Jan 2011

Bluechiip, STMicroelectronics enter partnership to manufacture unique MEMS-based tracking tags

STMicroelectronics, the leading supplier of MEMS devices for consumer and portable applications, and Bluechiip Limited, an innovative early-stage company that has developed a groundbreaking tracking solution, today announced that the two companies are to cooperate in the manufacturing of unique MEMS-based tracking tags, aimed at a range of different markets, but initially in healthcare, such as biobanks.

20 Jan 2011

University of Minnesota grants Cellectis rights related to TAL effector-mediated DNA recognition and cleavage

Cellectis, the French genome engineering specialist, has announced today that it has signed an exclusive license agreement with the University of Minnesota that grants Cellectis the worldwide right to use inventions related to TAL effector-mediated DNA recognition and cleavage. This revolutionary approach for the targeted modification of genomes was developed by the University of Minnesota and Iowa State University.

20 Jan 2011

Scarab Genomics, WIST enter research agreement to produce isoprene from paper, pulp mill waste streams

Scarab Genomics, a leader in the development of production E. coli strains based on reduced genome technology and the Wisconsin Institute for Sustainable Technology at the University of Wisconsin-Stevens Point have entered into a research agreement to produce isoprene from paper and pulp mill waste streams.

20 Jan 2011

Exciton, ULURU sign agreement to develop and market Altrazeal exSALT product

ULURU Inc. announced today that it has signed a Binding Letter of Intent with Exciton Technologies Inc. to develop and market a product that will combine Altrazeal® with Exciton's proprietary exSALT™ Antimicrobial Technology.

20 Jan 2011

Boston Scientific announces merger agreement to acquire Atritech

Boston Scientific Corporation today announced the signing of a definitive merger agreement, under which the Company will acquire Atritech, a privately held company based in Plymouth, Minnesota.

19 Jan 2011

Lab21 acquires Microgen Bioproducts

Lab21 Limited, the Cambridge, UK-based specialist in personalised medicine and clinical diagnostics, has announced that it has acquired Microgen Bioproducts Ltd a UK company specialising in the development, manufacture and sale of diagnostic tests to identify diseases and organisms which pose a threat to health.

6 Jan 2011

Renal Advantage, Liberty Dialysis announce deal closure

Renal Advantage and Liberty Dialysis, which last month agreed to combine to form the third largest provider of dialysis services in the U.S., today announced that they have closed their deal. The transaction – terms of which were not disclosed – was completed on December 17, 2010. The combined organization has 5,300 employees serving more than 19,000 patients in 260 locations in 32 states.

23 Dec 2010

Cerner, Baxa sign strategic reseller agreement for DoseEdge Pharmacy Workflow Manager

Cerner Corporation and Baxa Corporation have signed a strategic reseller agreement for the Baxa DoseEdge Pharmacy Workflow Manager. The agreement enables Cerner to market and resell the Baxa DoseEdge System as part of an integrated Cerner offering. Cerner clients now have access to a broader suite of solutions and certified integration for dose tracking from compounding to delivery.

6 Dec 2010

Hybrigenics receives EUR 800,000 payment from Oseo

Hybrigenics (ALHYG), a bio-pharmaceutical group with a focus on research and development of new cancer treatments and a fully-owned subsidiary specialized in protein interactions services, today announces it has received EUR 800,000 as the second and last payment of a EUR 1.4 million refundable grant contract originally signed with France’s innovation agency, Oseo Innovation, in 2008.

2 Dec 2010

GFS solution to Cholera

GFS BioProtect™ Effluent Remediator kills Vibrio cholerae O: 1, serotype Ogawa to Log 3 immediately, and the kill rate for this and several other pathogens continues to improve over time. The product breaks down B Class biomass (latrine and septic tank waste) into A class biomass suitable for reuse.

28 Nov 2010

Pharma enhances its focus on Asia-Pacific partnerships

While the Japanese market still dominates deal activities in the Asia-Pacific (APAC) region, companies and research institutes in emerging APAC countries have recently been attracting high calibre collaborators, according to the latest analysis by Datamonitor.

28 Nov 2010

Business / Finance

Meridian Bioscience first quarter net sales decrease 12% to $37.3 million

FDA approves Spectranetics PMA for manufacturing site change for CVX-300 laser system

UnitedHealth Group reports net earnings of $4.10 per share for 2010

Ingenix announces formation of new Life Sciences division

inVentiv Health signs definitive agreement to purchase i3 clinical development businesses from Ingenix

Cognizant to deliver commercial operations solutions to Lilly

Medidata extends Grants Manager web-based budgeting application with new Contracting module

Waters signs land-purchase agreement with Royal Bank of Scotland for new MS Headquarters in UK

Precedent Health announces formal launch

Bluechiip, STMicroelectronics enter partnership to manufacture unique MEMS-based tracking tags

University of Minnesota grants Cellectis rights related to TAL effector-mediated DNA recognition and cleavage

Scarab Genomics, WIST enter research agreement to produce isoprene from paper, pulp mill waste streams

Exciton, ULURU sign agreement to develop and market Altrazeal exSALT product

Boston Scientific announces merger agreement to acquire Atritech

Lab21 acquires Microgen Bioproducts

Renal Advantage, Liberty Dialysis announce deal closure

Cerner, Baxa sign strategic reseller agreement for DoseEdge Pharmacy Workflow Manager

Hybrigenics receives EUR 800,000 payment from Oseo

GFS solution to Cholera

Pharma enhances its focus on Asia-Pacific partnerships

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News